Conditioned pain modulation predicts duloxetine efficacy in painful diabetic neuropathy.
Pain. 2012 Apr 3
Mellar Davis
25 Jun 2012
|
Interesting Hypothesis, New Finding
Dr Yarnitsky and colleagues were able to phenotype pain and predict response to an analgesic for the first time. This is an importance step forward in managing neuropathic pain.
Condition and pain modulation (CPM) or diffuse noxious inhibitory control (DNIC) was first described in 1979 by Le Bars {1,2}. DNIC occurs when a nociceptive...
INDIVIDUAL SUBSCRIPTIONS
Get instant access to Article Recommendations from more than 5,000 expert scientists and clinical researchers, assisted by 5,000 associates, by taking out a monthly subscription. The first month of your subscription will be free of charge.
Start your personal subscription today.
Subscribe for $9.95/monthINSTITUTIONAL SUBSCRIPTIONS
Send a recommendation to your institution's librarian or information manager to request an extended free trial for all users.
Recommend to your LibrarianIf you are a librarian or information manager, you may request an extended free trial for your academic or corporate institution.
Request an Institutional Trialyour institution might be eligible for free access via our sponsorship scheme. Check our sponsorship page.
If you think you should be able to access this content, please contact us.